Skip to main content

Table 2 Independent predictors of all-cause mortality at 20 years of the entire study cohort

From: Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial

  HR 95 % CI P value
Lower Upper
Fibrate treatment 0.90 0.82 0.98 0.026
Past MI 1.45 1.30 1.64 <0.001
Glucose (per 1 mg/dl) 1.01 1.005 1.01 <0.001
Age (per year increment) 1.09 1.08 1.10 <0.001
BMI (per unit) 1.03 1.01 1.04 <0.001
NYHA functional class ≥ II 1.13 1.04 1.22 0.005
TG ≥200 mg/dl 1.04 0.92 1.18 0.52
Diabetes mellitus 1.34 1.14 1.58 <0.001
  1. Model further adjusted for hypertension, gender, baseline HDL and use of non-study lipid lowering medication as a time dependent covariate